- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care & Life Sciences
WellPoint among 13 picked to join California exchange
May 23, 2013
Bloomberg NewsCalifornia residents who choose to buy health insurance through the state exchange being created by the Affordable Care Act
may end up paying higher premiums.
MoreForecast: Cash to reign in health care
May 20, 2013
J.K. WallWith premiums for health insurance likely to head north next year as President Obama’s health care reform law fully
takes effect, both individuals and employers will pay for more health care out of their own funds and buy less insurance.
MoreLilly study: 1 in 5 Alzheimer's patients misdiagnosed
May 20, 2013
J.K. WallThe study results, which will be released Monday afternoon, are part of Indianapolis-based Lilly’s campaign to get Medicare
to pay for use of its brain imaging agent Amyvid.
MoreWork stops on Greenwood pharmaceutical plant
May 20, 2013
IBJ Staff and Associated PressGreenwood officials three years ago approved $8.4 million of incentives for the Elona Biotechnologies project, including the
construction loan.
MoreMobile health apps could cut into state companies' market share
May 18, 2013
J.K. WallThe future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source:
smartphone apps.
MorePANEL: Life sciences will see radically different future
May 17, 2013
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues
of venture capital, digital health innovations and research university entrepreneurship.
MorePanel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.
The following is an unedited transcript of the discussion.
Canada’s Supreme Court won’t hear Lilly appeal on Zyprexa
May 16, 2013
Bloomberg NewsEli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major
developed countries.
MoreSurprise director departures boost WellPoint shares
May 14, 2013
Greg AndrewsOutside observers cast the departures of Lenox Baker, Sheila Burke and Susan Bayh as a positive that will allow new CEO Joseph
Swedish to recast the board.
MoreLechleiter's surgery to repair heart goes as planned
May 14, 2013
Bloomberg NewsEli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta
is functioning as intended, the Indianapolis-based drugmaker said.
MoreThree WellPoint directors step down, cite personal reasons
May 13, 2013
Bloomberg NewsLenox Baker, Sheila Burke and Susan Bayh resigned from the board effective immediately, Indianapolis-based WellPoint said
Monday in a regulatory filing.
MoreMichigan doctor named dean of IU School of Medicine
May 13, 2013
Associated PressDr. Jay Hess was picked to become the 10th dean in the school of medicine's 110-year history and the first dean in the past
five to come from outside IU.
MoreIndiana device makers absorbing Obamacare excise tax
May 13, 2013
J.K. WallThe state's medical-device companies are finding that they cannot pass on the new medical-device tax created by Obamacare
to their hospital customers, causing them to continue to make cuts and to look to foreign markets for more profitable growth.
MoreStudy rebuts hospitals' argument on Medicare, rising costs
May 13, 2013
Rather than raising prices on private health insurers to make up for inadequate payments from the government, hospitals across
the country have been raising prices just because they can, according to a new study.
MoreTruck insurer’s new jobs to boast gold-plated pay
May 11, 2013
The 133 full-time jobs the truck and auto insurer plans to add over the next five years will pay around $60 an hour, or nearly
$125,000 a year.
MoreRuling keeps church ensnared in life insurance nightmare
May 11, 2013
Greg AndrewsA federal bankruptcy judge has slapped down an Anderson church that attempted to blame its bank for a failed scheme to finance
church upgrades by buying life insurance policies on its elderly members.
MoreLilly stops development on cancer drug after failed study
May 10, 2013
Bloomberg NewsThe drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual
sales by 2018.
MoreWarner Transitional Services to close, lay off 112
May 8, 2013
IBJ StaffWarner relies on funds from the Indiana Family and Social Administration, but the FSSA recently decided to end that funding
after numerous complaints against the company went unresolved.
MoreGovernor taps ex-WellPoint CEO Braly for IEDC board
May 7, 2013
J.K. WallThe appointment is the first high-profile post that Braly, 51, has accepted since she was ousted from the top spot at the
Indianapolis-based health insurer in August.
MoreLilly CEO to step down temporarily due to surgery
May 6, 2013
J.K. WallJohn Lechleiter has been suffering from a dilated aorta, Eli Lilly and Co. said Monday. Current CFO Derica Rice will take
his place until later this summer.
MoreBiosciences institute aims for $300M endowment
May 6, 2013
J.K. WallThe effort to launch the Indiana Biosciences Research Institute got $25 million from the Legislature, but the life sciences
institutions backing the effort have set their funding sights much higher.
MoreLilly's sales-force restructuring to affect 1,600-plus
May 6, 2013
J.K. WallLilly will eliminate 1,624 positions from its U.S. sales force in July, according to a notice the company made to state officials.
But some of those workers may be rehired by the firm.
MoreLilly taking hard look at Pfizer's new Viagra strategy
May 6, 2013
Associated PressMajor drugmakers, including Indianapolis-based Eli Lilly and Co., are closely watching Pfizer Inc.'s plan to sell Viagra directly
to consumers. The bold move blows up the drug industry's distribution model.
MoreNew seed fund aims to make Indiana a hotbed for digital health startups
May 4, 2013
J.K. WallInfuse Accelerator hopes to make early-stage investments in 12 to 15 companies a year.
MoreMedicaid expansion in Pence's hands after session
April 30, 2013
Associated PressThe question of whether Indiana will expand Medicaid is now back in Gov. Mike Pence's hands, after lawmakers wrapped up
their session without mandating he expand coverage under the federal health care law or suggesting the route he should take.
MoreLawmakers pass Medicaid ball back to Pence
April 29, 2013
J.K. WallAfter a four-month debate, the Legislature ended pretty much where it started on a potential expansion of Medicaid: Lawmakers
are letting Gov. Mike Pence go one-on-one with President Obama to see what kind of deal he can strike.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
these guys only skill was to steal from other's hard earned savings.
I voted for him last time and it WAS the LAST time. He needed to to quit running around the world on useless trips, and giving our $$ away to sports teams. I'll vote for anyone but Ballard next time. BTW...we gave $40M to the Pacers and cannot even watch the games on TV.
For the people concerned about traffic, you should know that mixed-use projects (like the one being proposed), actually allows for and encourages more people to walk and bike, thereby mitigating additional automobile traffic. If we continue to design and build suburban-type projects in the City (i.e. automobile-oriented projects), we are not offering anything different from what the suburbs offer, which means we will continue to lose jobs/people to the suburbs. The reason Broad Ripple is somewhat successful today is that people want to live in a place that offers the convenience of being able to walk/bike to restaurants, retail, nightlife, the Monon, etc. Why would you not want to support a project that is complimentary to what already makes the area desirable? The real argument with this project should be its lack-luster design and layout, not the density.
It is unfortunate that there is a perception that celebrities validate an event. The Indy 500 stands on its own, especially for those coming in from out of town. It was always so disturbing to read the gushing descriptions of Ashley Judd threaded throughout the local coverage. Very happy that era is at an end.
Good ole' Obamacare. Thanks liberals and those who didn't bother to vote.